Artemis Therapeutics, Inc. Sample Contracts

AutoNDA by SimpleDocs
EXHIBIT 2.1 STOCK PURCHASE AGREEMENT by and among COMVEST CAPITAL PARTNERS, LLC
Stock Purchase Agreement • March 30th, 2001 • Lil Marc Inc • Plastics products, nec • New York
AGREEMENT
Agreement • June 26th, 2003 • Inksure Technologies Inc • Plastics products, nec • London
WHEREAS:
Purchase Agreement • January 21st, 2010 • Inksure Technologies Inc. • Miscellaneous chemical products • New York
RECITAL
Employment Agreement • November 14th, 2002 • Lil Marc Inc • Plastics products, nec • New York
COMMON STOCK PURCHASE WARRANT ARTEMIS THERAPEUTICS, INC.
Artemis Therapeutics, Inc. • October 25th, 2017 • Miscellaneous chemical products

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October __, 2022 (the “Termination Date) but not thereafter, to subscribe for and purchase from Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

BY AND AMONG
Agreement and Plan of Merger • July 10th, 2002 • Lil Marc Inc • Plastics products, nec • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 25th, 2017 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 23, 2017, between Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

EXHIBIT A AGREEMENT AND PLAN OF MERGER
Agreement and Plan of Merger • October 8th, 2002 • Lil Marc Inc • Plastics products, nec • New York
AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT (Signed in Tel Aviv on 1st of March, 2011)
Employment Agreement • March 30th, 2011 • Inksure Technologies Inc. • Miscellaneous chemical products
AGREEMENT
Agreement • December 6th, 2010 • Inksure Technologies Inc. • Miscellaneous chemical products
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 3rd, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2016, between New York Global Innovations Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

BY AND AMONG
Agreement and Plan of Merger • July 15th, 2002 • Lil Marc Inc • Plastics products, nec • New York
AutoNDA by SimpleDocs
AGREEMENT AND PLAN OF MERGER BY AND AMONG NEW YORK GLOBAL INNOVATIONS INC., ARTEMIS ACQUISITION CORP. AND ARTEMIS THERAPEUTICS INC. AUGUST 2, 2016
Agreement and Plan of Merger • August 3rd, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products • Delaware

THIS AGREEMENT AND PLAN OF MERGER is entered into as of August 2, 2016 by and among New York Global Innovations Inc., a Delaware corporation (“Parent”), Artemis Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Corp.”), and Artemis Therapeutics Inc., a Delaware corporation (the “Company”).

Confidential portions have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission (the “Commission”)** LICENSE AGREEMENT
License Agreement • June 29th, 2017 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • London

This License Agreement (this “Agreement”) is entered into on May 31, 2016, by and between Hadasit Medical Research Services & Development, Ltd. of Jerusalem Bio Park, Hadassah Ein-Kerem Medical Center, P.O.B. 12000, Jerusalem 91120 (“Hadasit”), Hong Kong University of Science and Technology R and D Corporation Limited (“RDC”, and collectively with Hadasit, “Licensors”) and Artemis Therapeutics Inc., a Delaware corporation, having a place of business at 1633 Broadway, New York, NY 10019 (“Company”). (Hadasit shall also be referred to herein as the “Leading Licensor”. Each of Hadasit, RDC and the Company, a “Party”, and collectively the “Parties”).

FORM OF INDEMNIFICATION AGREEMENT
Form of Indemnification Agreement • November 21st, 2022 • Artemis Therapeutics, Inc. • Miscellaneous chemical products • Delaware

This Indemnification Agreement (“Agreement”) is made as of the ___ day of _____, 2022, by and Artemis Therapeutics, Inc., a Delaware corporation (the “Corporation”), and _____________ (“Indemnitee”), a director and/or officer of the Corporation.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • August 29th, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2016, between New York Global Innovations Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

STOCK OPTION AGREEMENT
Stock Option Agreement • March 30th, 2017 • Artemis Therapeutics, Inc. • Miscellaneous chemical products

THIS STOCK OPTION AGREEMENT (the “Agreement”) is made and entered into as of March__, 2017, by and between Artemis Therapeutics, Inc., a Delaware corporation (the “Corporation” or “Company”) and Dr. Dana Wolf (the “Optionee”). This Agreement is being issued in place of that certain option agreement between Artemis Pharma Inc. (formerly known as Artemis Therapeutics, Inc.), a subsidiary of the Corporation, and the Optionee, dated August 22, 2016 (the “Grant Date”).

EXHIBIT 2.1
Agreement and Plan of Merger • July 22nd, 2003 • Inksure Technologies Inc • Plastics products, nec • Nevada
STOCK REPURCHASE AGREEMENT
Stock Repurchase Agreement • September 6th, 2011 • Inksure Technologies Inc. • Miscellaneous chemical products

This Stock Repurchase Agreement (this “Agreement”) dated as of August 31, 2011 by and between Inksure Technologies Inc., a Delaware corporation with its principal business address at 589 Fifth Avenue, Suite 401, New York, New York 10017, USA (the “Company”) and Dr. Haim Kaplan, an Israeli citizen with an address at 31 Shmuel Tamir St., Tel Aviv, 69637, Israel (“Kaplan”).

Non-Qualified Stock Option Agreement
Qualified Stock Option Agreement • October 18th, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products

Artemis Therapeutics Inc., a Delaware corporation (the “Company”), hereby grants the following stock option (the “Option”) pursuant to its 2016 Stock Option and Incentive Plan. The terms and conditions attached hereto are also a part hereof.

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreement • January 5th, 2018 • Artemis Therapeutics, Inc. • Miscellaneous chemical products

This First Amendment (the “Amendment”), dated as of January 3, 2018, of Employment Agreement (the “Employment Agreement”), dated as of August 1, 2017, between Brian M. Culley, an individual having an address at 2153 Whisper Wind Ln., Encinitas, CA 92024 (the “Executive”) and Artemis Therapeutics Inc., a Delaware corporation (the “Company”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Employment Agreement.

CONSULTING AGREEMENT
Consulting Agreement • August 14th, 2014 • New York Global Innovations Inc. • Miscellaneous chemical products • New York

THIS CONSULTING AGREEMENT (this “agreement”) is made as of July 1, 2014 by and between New York Global Innovations, Inc., and its wholly owned subsidiaries (collectively the ACompany@) and Gilat Technologies (in formation), a company organized under the laws of the State of Israel with offices located at 8 Rachel Street, Givatayim, (the AConsultant@).

Contract
Artemis Therapeutics, Inc. • July 5th, 2022 • Miscellaneous chemical products

This is a translation into English of the official Hebrew version of the agreement between Manuka Ltd. and Chic Cosmetics Industries 1989 Ltd. In the event of a conflict between the English and Hebrew texts, the Hebrew text shall prevail.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!